全文获取类型
收费全文 | 2329999篇 |
免费 | 176037篇 |
国内免费 | 5599篇 |
专业分类
耳鼻咽喉 | 30459篇 |
儿科学 | 75980篇 |
妇产科学 | 64793篇 |
基础医学 | 345013篇 |
口腔科学 | 65069篇 |
临床医学 | 223816篇 |
内科学 | 448691篇 |
皮肤病学 | 48415篇 |
神经病学 | 191786篇 |
特种医学 | 85112篇 |
外国民族医学 | 604篇 |
外科学 | 326365篇 |
综合类 | 50668篇 |
现状与发展 | 4篇 |
一般理论 | 990篇 |
预防医学 | 198336篇 |
眼科学 | 52193篇 |
药学 | 171783篇 |
12篇 | |
中国医学 | 4783篇 |
肿瘤学 | 126763篇 |
出版年
2019年 | 19295篇 |
2018年 | 26445篇 |
2017年 | 20163篇 |
2016年 | 21857篇 |
2015年 | 25090篇 |
2014年 | 34828篇 |
2013年 | 53778篇 |
2012年 | 73421篇 |
2011年 | 78157篇 |
2010年 | 45434篇 |
2009年 | 42687篇 |
2008年 | 72347篇 |
2007年 | 77068篇 |
2006年 | 76765篇 |
2005年 | 74633篇 |
2004年 | 71457篇 |
2003年 | 68207篇 |
2002年 | 66021篇 |
2001年 | 101941篇 |
2000年 | 104542篇 |
1999年 | 88093篇 |
1998年 | 25302篇 |
1997年 | 22994篇 |
1996年 | 23028篇 |
1995年 | 21857篇 |
1994年 | 20410篇 |
1993年 | 19114篇 |
1992年 | 70374篇 |
1991年 | 69300篇 |
1990年 | 67215篇 |
1989年 | 64304篇 |
1988年 | 59624篇 |
1987年 | 58450篇 |
1986年 | 55764篇 |
1985年 | 53181篇 |
1984年 | 40184篇 |
1983年 | 34833篇 |
1982年 | 20903篇 |
1979年 | 37603篇 |
1978年 | 27270篇 |
1977年 | 22497篇 |
1976年 | 21575篇 |
1975年 | 22623篇 |
1974年 | 27645篇 |
1973年 | 27247篇 |
1972年 | 25413篇 |
1971年 | 23759篇 |
1970年 | 22234篇 |
1969年 | 20645篇 |
1968年 | 19472篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
991.
Thirty women, 25 with incontinence and five asymptomatic volunteer control subjects, were evaluated urodynamically by a variety of techniques, including ultrasound cystourethrography. The ultrasound evaluation was found to be a helpful adjunct in diagnosis. In comparison with radiologic techniques it offers more safety, more comfort, more privacy, more viewing time, and less cost. Bladder and urethral morphology during voiding activity and the amount and direction of urethrovesical mobility are easily determined by utilizing ultrasound techniques. 相似文献
992.
The incidence of lower urinary tract dysfunction increases during the climacteric, and there is embryological, biochemical and epidemiologic evidence to suggest that depleted estrogen status is at least partially responsible. Twelve climacteric women underwent full assessment before and 1 year after treatment with a 50 mg subcutaneous estradiol implant +5 mg norethisterone for 7 days per month. Assessment consisted of a symptoms questionnaire, midstream urine sample, uroflowmetry, videocystourethrography with pressure flow studies, and urethral pressure profilometry. Subjectively, only the symptom of nocturia significantly improved. There was no change in flow variables but there was a significant decrease in residual urine and the degree of bladder base descent. Cystometric capacity was slightly but significantly decreased, and two patients developed genuine stress incontinence whilst on treatment. Nonetheless, there was a significant improvement in urethral pressures at rest but not under stress. This effect was predominantly in the proximal urethra. These data do not support the contention that estrogen replacement therapy is beneficial for lower urinary tract dysfunction during the climacteric. 相似文献
993.
Summary Intracavitary application of ultrasound was first performed for diagnostic purposes in 1967; since that time, it has been
more and more widely used. As far as the gastrointestinal tract is concerned, endoscopically controlled ultrasonic probes
provide visualization of the various layers of the intestinal wall. It is therefore possible to describe lesions of the esophagus,
stomach, and the rectum with regard to their nature and depth of infiltration. Furthermore, periesophageal and perigastric
organs can be visualized. It has become evident that endosonography is particularly important for pretherapeutic staging of
tumors of the esophagus, stomach, and rectum. Here prospective comparative studies confirm the superiority of this new diagnostic
procedure when compared to the methods available to date. 相似文献
994.
D.L. Morgan J.R. Bucher M.R. Elwell H.S. Lilja A.S. Krishna Murthy 《Food and chemical toxicology》1990,28(12):839-845
Studies were conducted to compare the toxicity of ethylene dichloride (EDC) in F344/N rats, Sprague-Dawley rats, and Osborne-Mendel rats. Ten rats/sex/group were exposed to EDC in drinking-water at 0, 500, 1000, 2000, 4000 and 8000 ppm for 13 wk. The highest concentration was limited by the maximum solubility of EDC in water (about 9000 ppm). In addition, F344/N rats (10/sex/group) were administered EDC in corn oil by gavage to compare toxicity resulting from bolus administration with that of continuous exposure in drinking-water. Gavage doses of EDC were within the range of total daily doses (in mg/kg body weight/day) resulting from exposure in drinking-water. EDC administered by gavage resulted in greater toxicity to F344/N rats than did administration of similar doses in drinking-water. All males receiving 240 and 480 mg/kg body weight and 9/10 females receiving 300 mg/kg body weight by gavage died before the end of the study. Necrosis of the cerebellum was observed in the brains of 3 males receiving 240 mg/kg body weight and 3 females receiving 300 mg/kg body weight. Hyperplasia and inflammation of the forestomach mucosa were observed in 8 male and 3 female rats that died or were killed in moribund condition. EDC caused minimal toxicity to F344/N, Sprague-Dawley and Osborne-Mendel rats at the drinking-water concentrations used in these studies; only female F344/N rats had EDC-related renal lesions. Based on mortality and EDC-related lesions, the no-effect levels for EDC administered by gavage to F344/N rats were 120 mg/kg body weight for males and 150 mg/kg body weight for females. 相似文献
995.
E Nakano T Yoshioka M Matsuda T Sonoda H Yano Y Ihara H Kuroda T Kishimoto T Sakurai K Uchida 《Hinyokika kiyo. Acta urologica Japonica》1990,36(5):635-642
Clinical effect of LM-001, a prostaglandin synthetic inhibitor developed from a drug delivery system, was evaluated in 54 patients with pain from urinary tract stones (stone pain) and 32 with vesical urgency after an operation on bladder or prostate. LM-001, felbinac ethyl incorporated in lipid microsphere, wes intravenously administered at the onset of stone pain or vesical urgency. Of 54 with stones and 32 with urgency, 53 and 29 were eligible for response, respectively. The symptoms improved or disappeared in some cases just after the administration and in the majority of patients within 15 minutes, in 49 of 53 patients with stone pain. Further, the effectiveness lasted over 24 hours in 26 of the 49 responding to this agent. On one hand, improvement or disappearance of vesical urgency was recognized in 25 of 29 patients, and the effectiveness was observed shortly after injection in 16 and lasted over 24 hours in 13 cases. Toxicities of this drug were investigated in 54 patients with stone pain and 32 with urinary urgency. Side effects consisted of pain at the injection site in 4, a slight fall of blood pressure in 1, slight visual disturbance in 1, body heat sensation in 1, leukocytosis in 3 and elevation of alkaline phosphatase in 1. These symptoms were transient and disappeared without use of any agent. LM-001 is concluded to be a useful drug for controlling stone pain and vesical urgency since an immediate effect, long durability and high response rates were obtained without severe side 相似文献
996.
It has become common practice to rely on fitted estimates ofapparent in vivo metabolic constants (e.g., Vmax and KM) inparameterization of PBPK models. Yet, quantitative estimatesof precision in these fitted parameters are not routinely reported.Such information is needed to assess the reliability of modelpredictions. The purpose of this study was to assess the precisionin estimates of Vmax and KM for chloroform, accounting for boththe statistical uncertainties in parameter estimates from individualdata sets and any additional uncertainty due to differencesin the parameter estimates derived from various experiments.Joint confidence regions for Vmax and KM from each experiment,generated using maximum likelihood techniques, were used toevaluate these questions. Three previously published data setswere considered. Estimates of Vmax and KM obtained from thesedata sets differed more than could be explained as a consequenceof a limited number of observations, measurement error, or stochasticerror. Issues associated with the use of maximum likelihoodtechniques to estimate joint confidence regions, the estimationof metabolic constants from individual experiments within agas uptake study versus the full data set, the degree of overlapin the joint confidence regions for metabolic constants obtainedfrom separate data sets, and the implications for risk assessmentare discussed. 相似文献
997.
998.
999.
Measurements were made of glutathione (GSH) levels, catalase activity and the oxidant sensitivity of the erythrocytes from
the koala (Phascolarctos cinereus) and the common brushtail possum (Trichosurus vulpecula). The oxidant sensitivity was tested by treating the haemolysates with either 0.55 him H2O2 or 1.4mm NaNO2. The erythrocytes of the koala had greater levels of GSH and catalase and yet were found to be more susceptible to oxidation
induced by both these oxidants. 相似文献
1000.
T. Akatsu T. Murakami K. Ono M. Nishikawa E. Tsuda S.-I. Mochizuki N. Fujise K. Higashio K. Motoyoshi M. Yamamoto N. Nagata 《BONE》1998,23(6):495-498
Osteoclastogenesis inhibitory factor (OCIF) is a novel secreted protein that inhibits osteoclastogenesis both in vitro and in vivo. In this study, we examined the effects of OCIF on serum calcium (Ca) concentrations in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. In normal mice, a single intraperitoneal injection of OCIF reduced serum Ca levels in a dose-dependent manner. Significant decrease in serum Ca (by 1.6 ± 0.3 mg/dL, n = 5) was observed 2 h after the injection of OCIF at 20 mg/kg and the hypocalcemic effect continued for up to 12 h. Serum phosphate (Pi) concentrations also decreased in response to OCIF. Urinary excretion of Ca, Pi, and creatinine did not change significantly after injection of OCIF or vehicle. In hypercalcemic, tumor-bearing nude mice, a single intraperitoneal injection of OCIF at 20 mg/kg resulted in a dramatic decrease in serum Ca (maximal decrease 2.8 ± 0.37 mg/dL, n = 11), which continued for up to 24 h. The results suggest that OCIF decreased serum Ca through its inhibitory effect on bone resorption. Furthermore, it is suggested that OCIF has therapeutic potential for the treatment of hypercalcemic conditions such as malignancy-associated hypercalcemia. 相似文献